The Pros and Cons of Adaptive DBS...
tmrwedition.com/2026/09/12/t…
Benjamin Stecher retweeted
You don't need any aggregated forms to get symptoms if you lose the functional protein, and you can survive aggregated forms if you have enough of the functional protein. For how long the field will ignore this?
linkedin.com/posts/kariem-ez…
Despite decades of research we don’t actually know if affected cells die. The vast majority of studies count markers (such as TH...) rather than neurons themselves. We have been counting the lights in the windows of a city, not the buildings themselves.
tmrwedition.com/2026/08/06/c…
Deep Brain Stimulation gave me my body back, but it temporarily cost me my identity. On the hidden realities of rewiring the self:
tmrwedition.com/2026/07/31/r…
It has been over 5 years since they burred holes all the way through my brain. Seems like a good time to answer the simple question: how am I doing these days?...
tmrwedition.com/2026/07/25/5…
The Past, Present and Future of Clinical Trials in Parkinson's Disease as well as a Critique of How, Who and What We Measure...
tmrwedition.com/2026/03/05/o…
Benjamin Stecher retweeted
The patient voice: "For my 80th birthday, I bought myself a new brain: my experiences with adaptive deep brain stimulation to assist my #Parkinsons"
bjsm.bmj.com/content/early/2…
Misfolded proteins aren't the cause of neurodegenerative diseases; they are debris in a system-wide energy failure.
Biology gives us a list of parts, but physics writes the manual.
Read more at the link below:
tmrwedition.com/2026/02/16/a…
Benjamin Stecher retweeted
A short but super cool video that gives a quick overview of our Nature paper on the SCAN of PD, along with videos showing patients with Parkinson's before and after non-invasive brain surface stimulation (see thread).🧠 nature.com/articles/s41586-0…
Benjamin Stecher retweeted
In Parkinson’s, we obsess over what α-synuclein becomes when aggregated, and ignore what neurons lose when its normal form disappears. New data in α-syn KO mice: hyposmia, apoptosis, impaired autophagy. Depletion may matter more than we think. linkedin.com/posts/alberto-e…
Bridging the Gaps: Lessons from a Decade in Parkinson's Disease Patient Advocacy
tmrwedition.com/2026/01/15/b…
Benjamin Stecher retweeted
Everyone’s hyped about “AI for Science.” in 2025! At the end of the year, please allow me to share my unease and optimism, specifically about AI & biology.
After spending another year deep in biological foundation models, healthcare AI, and drug discovery, here are 3 lessons I learned in 2025.
1. Biology is not “just another modality.”
The biggest misconception I still see:
“Biology is text + images + graphs. Just scale transformers.”
No. Biology is causal, hierarchical, stochastic, and incomplete in ways that language and vision are not.
Tokens don’t correspond cleanly to reality.
Labels are sparse, biased, and often wrong.
Ground truth is conditional, context-dependent, and sometimes unknowable.
We’ve made real progress—single-cell, imaging, genomics, EHRs are finally being modeled jointly—but the hard truth is this:
Most biological signals are not supervised problems waiting for better loss functions.
They are intervention-driven problems. They demand perturbations, counterfactuals, and mechanisms, beyond just prediction.
Scaling obviously helps. But without causal structure, scaling mostly gives you sharper correlations.
2025 reinforced my belief that biological foundation models must be built around perturbation, uncertainty, and actionability, not just representation learning.
2. Benchmarks are holding biology back more than compute is.
Let’s be honest: Benchmarking in AI & biology is still broken.
Everyone reports SOTA. Everyone picks a different dataset slice.
Everyone tunes for a different metric. Everyone avoids prospective validation.
We’ve imported the worst habits of ML benchmarking into a domain where stakes are much higher. In biology and healthcare, a 1% gain that doesn’t transfer is worse than useless—it’s misleading.
What’s missing isn’t more benchmarks. It’s hard benchmarks:
•Prospective, not retrospective
•Perturbation-based, not static
•Multi-site, not single-lab
•Failure-aware, not leaderboard-optimized
If your model only works on the dataset that created it, it’s not a foundation model—it’s a dataset artifact.
In 2026, we need fewer flashy plots and more humility, rigor, and negative results.
3. “Reasoning” in biology is not chain-of-thought.
There’s a growing tendency to directly apply the word reasoning onto biological LLMs.
Let’s be careful.
Biological reasoning isn’t verbal fluency, longer context windows, or prettier explanations. Those are surface-level improvements. Real reasoning in biology shows up elsewhere: in forming hypotheses, deciding which experiments to run, updating beliefs when perturbations fail, and constantly trading off cost, risk, and uncertainty.
A model that explains a pathway beautifully but can’t decide which experiment to run next is not reasoning, it’s narrating.
2025 convinced me that the future lies in agentic biological AI:
systems that couple foundation models with experimentation, simulation, and decision-making loops.
Closing thought:
AI & biology is not lagging behind AI for code or language. It’s just playing a harder game.
The constraints are real. The data is messy. The feedback loops are slow. The consequences matter.
If 2025 clarified anything for me, it’s this:
We won’t make progress by treating biology like text. We’ll make progress by building AI that behaves more like a scientist : skeptical, iterative, and willing to be wrong.
Onward to 2026.
Benjamin Stecher retweeted
Can prions carry biological information?
The answer is definitely NO, not in a million years.
We explain why in this recently published paper: pubs.acs.org/doi/10.1021/acs…
Information is actually lost during amyloid formation (pic).
More discussion here: linkedin.com/feed/update/urn…
I started seriously going to the gym just before my 40th birthday. I still remember having to use walking sticks just to hobble up the hill to get there. It is now nearly 15 months later and the results in the pictures below speak for themselves.
I owe much of that to the fusion of stubborn will and cutting-edge technology within me. Over 4 years ago, with crucial support from @UHN and @Medtronic's team, Dr. Alfonso Fasano and I decided to turn on my adaptive Deep Brain Stimulator.
I have lost 30 pounds since and feel about as good as I can remember. If you're looking for a sign to start—this is it. Hobbling to the gym that day was the best birthday present I could have possibly given myself. (Below is 15 months ago)
youtube.com/shorts/rk-IiHflu…
A month out from another battery replacement surgery and nearly back to full strength today...
youtube.com/shorts/4YxYYpEf7…
Benjamin Stecher retweeted
"We suggest this search is in vain. The problem lies not in the population but in the framework itself"
Shots fired!
@AlbertoEspay & colleagues ask probing questions regarding αSyn-SAA-based staging for #Parkinsons progression
movementdisorders.onlinelibr…
Benjamin Stecher retweeted
How does physics inform neurodegeneration? Supersaturation lowers the nucleation barrier for the precipitation of monomeric proteins into their pathological state. In normal aging, replacement matches loss; in accelerated aging, it does not. (1/4)
onlinelibrary.wiley.com/doi/…
Benjamin Stecher retweeted
Only 2 more days, and only a few last discounted rooms left!
Hurry up and register to the GBA1 meeting in Montreal, June 5-7! And make use of the discounted hotel rooms at the conference venue! More details, including preliminary program, in the link below. Also - very generous travel awards for trainees!
give.michaeljfox.org/event/g…












